Sensio Air is a global leader in indoor air quality monitoring and pathogen detection, pioneering the use of real-time sensors and artificial intelligence to transform the way we understand and manage the air we breathe. Sensio's cutting-edge technology identifies airborne particles, allergens, and pollutants down to 1 micron, enabling predictive insights that help individuals and businesses safeguard health and well-being. With patented technology for both AI diagnostics and the detection technology on top of a proprietary biosignature (Large Pathogen Model) of over 2000 identified airborne pathogens, Sensio has revolutionized industries from healthcare to commercial real estate by providing precise, actionable data on indoor environments.
In a major leap forward, Sensio Air has partnered with IBM Watson X to redefine how buildings are managed globally. This new direction leverages sensor fusion technology, Large Language Models (LLMs), and Convolutional Neural Networks (CNNs) to create an AI-driven ecosystem where buildings can effectively “self-heal.” This system uses real-time data and AI to monitor, predict, and prevent issues such as air quality degradation, HVAC malfunctions, and even energy inefficiencies. By automating these processes, Sensio is tapping into a $37 trillion market and delivering one of the world’s most comprehensive AI systems for building management.
Sensio’s AI and recommendation engines draw from over seven years of expertise in monitoring and improving indoor air quality, ensuring that its systems not only detect potential issues but also provide tailored, practical solutions. The system integrates seamlessly into Building Management Systems (BMS), enabling facilities managers to manage large-scale operations with unprecedented efficiency, all while ensuring healthier, safer environments for occupants.
If you’re interested in learning more or you’d like to read our in depth guides, join our newsletter.